Biotheranostics Inc.
San Diego, CA Biotheranostics, Inc. Part of Hologic, Inc.
- UEI
- EL5WDRRT6895
- CAGE
- 1FJJ9
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Hologic, Inc.
Parent
WHWJBKU5SX73
- Biotheranostics Inc. EL5WDRRT6895
-
Hologic, Inc.
Parent
WHWJBKU5SX73
- SAM.gov registration date
- Physical address
- 6333 Sequence Dr, San Diego, CA 92121, USA
- Website
- biotheranostics.com
- Founded
- 2008
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Breast cancer index (BCI) test | Defense Health Agency | $139,428 | |
| Breast cancer index testing 81518. | Defense Health Agency | $139,428 | |
| Breast cancer index testing. | Defense Health Agency | $116,190 | |
| Breast cancer index testing | Defense Health Agency | $139,428 | |
| Breast canceer index (BCI) | Veterans Integrated Service Network 17 | $256,599 |
About Biotheranostics Inc.
Biotheranostics Inc., a division of Hologic Inc., is a San Diego-based medical diagnostics company specializing in advanced molecular diagnostics and genomic testing services. Registered as a self-certified small disadvantaged business since 2000, the company provides precision oncology solutions that leverage genomic analysis to guide cancer treatment planning and improve clinical outcomes. Biotheranostics has established itself as a trusted federal contractor, delivering specialized cancer diagnostic capabilities to support military healthcare operations and veteran services through multiple awards from the Department of Defense and Department of Veterans Affairs. The company's federal contracting portfolio demonstrates consistent capability in delivering advanced molecular diagnostic services to military treatment facilities and veteran healthcare systems across the country.
Biotheranostics Inc. has secured eight prime federal contract awards totaling approximately $1.04 million between May 2021 and September 2025, all focused on its flagship Breast Cancer Index (BCI) testing service and cancer identification testing. These awards have been issued by the Defense Health Agency and the Department of Veterans Affairs' Veterans Integrated Service Networks, specifically VISN 6 and VISN 17. The company's primary deliverable is the Breast Cancer Index genomic diagnostic test, which provides genomic analysis to support cancer screening, diagnosis, and treatment planning for military service members and veterans. Award amounts have ranged from $7,900 to $256,599, with the majority structured as firm fixed-price purchase orders with no set-aside designations. Notable performance locations include the company's headquarters in San Diego, California, Walter Reed National Military Medical Center in Bethesda, Maryland, and various VA facilities across VISN regions. All contracts have been awarded as prime federal contract vehicles with no subcontracting relationships indicated in the available documentation, underscoring Biotheranostics' direct role as a service provider to federal healthcare agencies.
Quick answers
What is Biotheranostics Inc.'s UEI?
Biotheranostics Inc.'s Unique Entity ID (UEI) in SAM.gov is EL5WDRRT6895.
What is Biotheranostics Inc.'s CAGE code?
Biotheranostics Inc.'s CAGE code is 1FJJ9.
What is Biotheranostics Inc.'s primary NAICS code?
Biotheranostics Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Where is Biotheranostics Inc. located?
Biotheranostics Inc.'s physical address in SAM.gov is 6333 Sequence Dr, San Diego, CA 92121, USA.
Is Biotheranostics Inc. registered in SAM.gov?
Yes. Biotheranostics Inc.'s SAM.gov registration is active through March 11, 2027.
Who is Biotheranostics Inc.'s parent company?
Biotheranostics Inc. is part of Hologic, Inc.
What is Biotheranostics Inc.'s most recent federal award?
Biotheranostics Inc.'s most recent federal contract award is Breast cancer index (BCI) test (HT001425PE112), from Defense Health Agency, on September 30, 2025.
On GovTribe
See Biotheranostics Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors